WithdrawnNot Applicable

Maximizing Benefit of Lung Cancer Screening Incidental Findings of Cardiovascular, Respiratory and Breast Measures

Stopped: Not funded by AHRQ

0Started 2024-12

Plain-language summary

The investigators will implement a patient-centered outcomes tool for participants in lung cancer screening programs that receive clinically important incidental findings relevant to heart, breast and lung health. The study objective is to evaluate participant response and clinical follow-up following implementation of a patient-centered incidental findings communication tool.

Who can participate

Age range55 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Eligible for lung cancer screening program * Presence of one of three incidental findings on low dose CT: coronary artery calcification, extensive breast density (for females), or emphysema Exclusion Criteria: * No incidental findings from lung cancer screening low dose CT

What they're measuring

Precaution Adoption Process Model (PAPM) health behavior stage

Timeframe: 3 years

Trial details

NCT IDNCT05900544

SponsorUniversity of Montana

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-10

View on ClinicalTrials.gov More Coronary Disease trials